Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1963 3
1966 3
1968 1
1969 2
1970 2
1972 2
1973 1
1974 4
1976 1
1977 2
1978 2
1979 5
1980 11
1981 6
1982 9
1983 6
1984 11
1985 11
1986 11
1987 11
1988 11
1989 11
1990 11
1991 16
1992 12
1993 14
1994 7
1995 6
1996 9
1997 15
1998 14
1999 20
2000 19
2001 25
2002 21
2003 15
2004 20
2005 20
2006 8
2007 16
2008 15
2009 11
2010 17
2011 9
2012 9
2013 16
2014 13
2015 15
2016 17
2017 14
2018 15
2019 18
2020 16
2021 14
2022 10
2023 10

Text availability

Article attribute

Article type

Publication date

Search Results

590 results

Results by year

Filters applied: . Clear all
Page 1
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial.
Ohba A, Morizane C, Ueno M, Kobayashi S, Kawamoto Y, Komatsu Y, Ikeda M, Sasaki M, Okano N, Furuse J, Hiraoka N, Yoshida H, Kuchiba A, Sadachi R, Nakamura K, Matsui N, Nakamura Y, Okamoto W, Yoshino T, Okusaka T. Ohba A, et al. Among authors: matsui n. Future Oncol. 2022 Jun;18(19):2351-2360. doi: 10.2217/fon-2022-0214. Epub 2022 May 5. Future Oncol. 2022. PMID: 35510484 Free article. Review.
[Stiff-Person Syndrome].
Matsui N, Tanaka K, Izumi Y. Matsui N, et al. Brain Nerve. 2023 Jun;75(6):749-754. doi: 10.11477/mf.1416202410. Brain Nerve. 2023. PMID: 37287358 Japanese.
[Stiff-Person Syndrome].
Matsui N, Tanaka K, Izumi Y. Matsui N, et al. Brain Nerve. 2021 May;73(5):640-646. doi: 10.11477/mf.1416201808. Brain Nerve. 2021. PMID: 34006698 Japanese.
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Among authors: matsui n. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
[Renal vein thrombosis].
Matsui N. Matsui N. Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):312-5. Ryoikibetsu Shokogun Shirizu. 1997. PMID: 9277750 Review. Japanese. No abstract available.
590 results